Cardiol Therapeutics Inc. Class A Common Shares (CRDL) is a publicly traded Healthcare sector company. As of May 21, 2026, CRDL trades at $1.31 with a market cap of $147.55M and a P/E ratio of 0.00. CRDL moved +3.17% today. Year to date, CRDL is +30.00%; over the trailing twelve months it is +16.07%. Its 52-week range spans $0.77 to $2.24. Analyst consensus is buy with an average price target of $8.50. Rallies surfaces CRDL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CRDL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.31 |
| Market Cap | $147.55M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.24 |
| 52-Week Low | $0.77 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover CRDL: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.50.